Cheryl R. Blanchard

Cheryl R. Blanchard (chief executive) discloses dealings in 2 companies, chiefly Anika Therapeutics, Inc. and Vigil Neuroscience, Inc. Over a trading history stretching from 15 June 2021 to 14 March 2026, the count stands at 16 filings.

On the market, this insider has only ever bought: 1 purchase, €99k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 2 share grants and 12 option exercises.

The record was last updated on 17 March 2026 with an option exercise in Anika Therapeutics, Inc. The clock since the last published purchase (14 March 2022) now reads 1,679 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.